Additionally, cancer cells, through the activation of oncogenic signaling pathways and the upregulation of cellular immune checkpoints such as programmed death ligand 1 (PD-L1), evade immune surveillance and exploit stromal cells to facilitate tumor progression (Van Der Woude et al., 2017). This evidence concerns the gene CD274 and cancer.